Certain Common Stock of Shuttle Pharmaceuticals Holdings, Inc. are subject to a Lock-Up Agreement Ending on 2-MAR-2023. These Common Stock will be under lockup for 184 days starting from 30-AUG-2022 to 2-MAR-2023.

Details:
The executive officers, directors and certain of significant stockholders have also agreed to a 12-month “lock-up” period, and any stockholders who own in excess of 1% of the outstanding shares of common stock will be subject to a six-month lock-up period, during which time, without the prior written consent of the underwriter, they will not, directly or indirectly, (i) offer, pledge, assign, encumber, announce the intention to sell, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, any shares of common stock or any securities convertible into or exercisable or exchangeable for common stock.